Table 5. Classification of effectiveness outcomes by EBI category (N = 81, n = 48) [29, 30, 32–35, 37–39, 41, 44, 47, 52, 53, 59, 65, 66, 68–71, 73–76, 81, 82, 89, 90, 93, 95, 97, 98, 100, 102, 105, 109, 110, 115–117, 119, 122, 134, 135, 138, 139, 141].

Type of Intervention	Regular HIV Testing for At-Risk Groups (N = 4)	Rapid Access to Testing Services (N = 16)	Rapid ART Intervention (N = 2)	One Stop Shop Model (N = 2)	Emergency Advice Service (N = 0)	Access to Mental Health Services (N = 6)	Role of the Pharmacist (N = 1)	Role of the Care Navigators (N = 19)	Individualised Plan of Care (N = 9)	Structured Follow-up (N = 19)	Diagnosis and Management of Co-infections (N = 1)	Diagnosis and Management of Comorbidities (N = 2)
Effectiveness outcome	Proportion of EBIs assessed per effectiveness outcomes; N†
Retention to care (N = 42)	2	0	0	1	0	4	1	12	6	14	0	2
Linkage to care (N = 41)	3	16	2	1	0	0	0	10	1	7	1	0
Medication adherence (N = 17)	0	0	0	0	0	3	1	5	4	4	0	0

N represents the total number of EBIs that are evaluation on effectiveness. n represents the number of publications in which these EBIs are evaluated. ART, antiretroviral therapy; HIV, human immunodeficiency virus.

^†The numbers reported in the table do not add up to the total number of EBIs evaluated on effectiveness outcomes (N = 81) as EBIs could be evaluated on >1 effectiveness outcome.